Skip to content

Prospective Cohort Study of Mini-probe Endoscopic Ultrasound in Assessing Inflammatory Bowel Disease Activity

Application of Mini-probe Endoscopic Ultrasound in Assessing Inflammatory Bowel Disease Activity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075162
Enrollment
Unknown
Registered
2023-08-28
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Disease

Interventions

Colonic Crohn's Disease:None
Normal control group:None

Sponsors

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Colonic Crohn's Disease Active/Remission Group: 1)Age 18-70 years; 2)Confirmed diagnosis of colonic Crohn's disease for at least 3 months with histological evidence; 3)Simplified Crohn's Disease Activity Index (CDAI) > 4 during the active phase of CD; 4)Simplified Crohn's Disease Activity Index (CDAI) = 4 during the remission phase of CD; 5)Signed informed consent form; Ulcerative Colitis Active/Remission Group: 1)Age 18-70 years; 2)Confirmed diagnosis of ulcerative colitis for at least 3 months with histological evidence; 3)Endoscopic Mayo score of 2-3 during the active phase of UC; 4)Endoscopic Mayo score of 0-1 during the remission phase of UC; 5)Signed informed consent form; Normal Control Group: 1)Age 18-70 years; 2)Patients without a diagnosis of IBS or IBD; 3)No history of underlying gastrointestinal diseases; 4)No recent intestinal infections in the past two weeks; 5)Normal colonoscopy findings; 6)Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1)History of gastrointestinal surgery; 2)Pregnant or planning to become pregnant; 3)Undifferentiated inflammatory bowel disease; 4)Coexisting colonic malignancy; 5)Presence of infectious colitis or diverticulitis; 6)Patients with any psychiatric disorders or individuals unable to cooperate with this trial.

Design outcomes

Primary

MeasureTime frame
Wall thickness;

Secondary

MeasureTime frame
White blood cell count;Hemoglobin;Platelet;C-reactive protein;Erythrocyte Sedimentation Rate;Albumin;Fecal calprotectin;Endoscopic score;

Countries

China

Contacts

Public ContactZhou Fan

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School

zhoufan24@hotmail.com+86 158 9596 9717

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026